Go Back

Hans-Christoph Diener

Hans-Christoph Diener

Institution:
Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty of the University Duisburg-Essen, Essen

Country:Germany

Biography

Hans-Christoph Diener, MD, PhD is affiliated with the Institute for Epidemiology at the University Duisburg-Essen. He was Professor of Clinical Neurosciences at the Medical Faculty of the University Duisburg-Essen from 2016-2019. He was Professor of Neurology, Chairman of the Department of Neurology and Director of the Essen Headache Centre at the University of Duisburg-Essen in Germany from 1989 to 2016. He was President of the German Neurological Society, President of the European Headache Federation (EHF), and the International Headache Society and chaired the German Headache Consortium

Professor Diener received his medical degree and doctorate at the Albrecht-Ludwigs-Universität in Freiburg, and continued his training there in the Departments of Neurology, Psychiatry, Internal Medicine and Surgery. Prior to joining the University of Essen in 1989, he was an Associate Professor of Neurology at the Department of Neurology at the University of Tübingen. He was a visiting Professor at the Neurological Sciences Institute in Portland, Oregon in 1984 and 1985 and at the University of New South Wales in Sydney in 1987 and 1988.

Professor Diener has been the PI in more than 30 trials on the acute treatment and prophylaxis of headache disorders.

Professor Diener has authored or co-authored 962 articles in peer reviewed journals (192 as first author, 21 in the NEJM), 352 invited reviews, and 367 book chapters, and served as the editor or author of 84 books. His h index is 120. He is the editor of Neurology Up2date, Arzneimitteltherapie, Info Neurologie & Psychiatrie, deputy editor of Cephalalgia, Stroke Editor for Current Neurology and Neurosciences Reviews and serves on the editorial boards of Lancet Neurology and Cerebrovascular Diseases.

Disclosures

In the last 3 years HCD received honoraria for participation in clinical trials, contribution to advisory boards or oral presentations from: Allergan, Amgen, Electrocore, Lilly, Novartis, Teva,Weber & Weber and WebMD. HCD has no ownership interest and does not own stocks of any pharmaceutical company. HCD serves on the editorial boards of Cephalalgia and Lancet Neurology. HCD chairs the Clinical Guidelines Committee of the German Society of Neurology and is a member of the Clinical Trials Guideline Committee of the IHS.